AN2 Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ALMITAS CAPITAL LLC | 11/17/2025 | 1.43 M | $1.81 M | 0.00% | 4.72% |
| VANGUARD GROUP INC | 11/07/2025 | 1.08 M | $1.37 M | 4.26% | 3.57% |
| PFIZER INC | 11/13/2025 | 715.30 K | $908.43 K | 0.00% | 2.36% |
| PEAPOD LANE CAPITAL LLC | 11/10/2025 | 589.22 K | $748.32 K | 1.11% | 1.95% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2025 | 563.91 K | $716.17 K | 3.57% | 1.86% |
| BANK OF NOVA SCOTIA | 11/14/2025 | 459.19 K | $583.18 K | 0.00% | 1.52% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 11/13/2025 | 456.46 K | $579.71 K | -7.86% | 1.51% |
| BANK OF MONTREAL /CAN/ | 11/13/2025 | 422.08 K | $536.04 K | 0.00% | 1.39% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 385.60 K | $489.71 K | -3.32% | 1.27% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 385.31 K | $489.34 K | -0.05% | 1.27% |
| BLACKROCK, INC. | 11/12/2025 | 320.91 K | $407.56 K | 0.51% | 1.06% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 267.90 K | $340.23 K | -0.63% | 0.88% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 249.35 K | $316.75 K | 0.00% | 0.82% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 223.34 K | $283.64 K | -6.30% | 0.74% |
| MORGAN STANLEY | 11/14/2025 | 190.77 K | $242.28 K | 7.03% | 0.63% |
| STATE STREET CORP | 11/14/2025 | 87.00 K | $110.49 K | 0.00% | 0.29% |
| RANGELEY CAPITAL, LLC | 11/14/2025 | 65.00 K | $82.55 K | 0.00% | 0.21% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 64.27 K | $81.62 K | 538.71% | 0.21% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 59.90 K | $76.07 K | 0.00% | 0.20% |
| UBS GROUP AG | 11/13/2025 | 56.69 K | $72.00 K | -8.56% | 0.19% |
| NORTHERN TRUST CORP | 11/14/2025 | 43.20 K | $54.86 K | 0.00% | 0.14% |
| CAPTRUST FINANCIAL ADVISORS | 11/19/2025 | 40.00 K | $50.80 K | 0.00% | 0.13% |
| CITADEL ADVISORS LLC | 11/14/2025 | 23.01 K | $29.23 K | 84.15% | 0.08% |
| PRIVATE ADVISOR GROUP, LLC | 11/13/2025 | 22.50 K | $28.58 K | 0.00% | 0.07% |
| XTX TOPCO LTD | 11/14/2025 | 18.54 K | $23.55 K | -28.81% | 0.06% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 14.28 K | $18.14 K | -16.56% | 0.05% |
| ACT ADVISORS, LLC. | 10/09/2025 | 13.20 K | $16.76 K | 100.00% | 0.04% |
| FEDERATED HERMES, INC. | 11/03/2025 | 11.88 K | $15.09 K | -2.90% | 0.04% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 10.18 K | $12.93 K | 0.00% | 0.03% |
| HIGHLINE WEALTH PARTNERS LLC | 10/14/2025 | 5.00 K | $6.35 K | 0.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 2.13 K | $2.70 K | -59.95% | 0.01% |
| FMR LLC | 11/13/2025 | 1.00 K | $1.27 K | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 303 | $385 | -2.88% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 300 | $384 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 200 | $254 | 0.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| INTEGRATED WEALTH CONCEPTS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
AN2 Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 42 institutional investors and hedge funds held shares of AN2 Therapeutics, Inc.. The most heavily invested institutionals were:
Almitas Capital LLC: 1.43 M
VANGUARD GROUP INC: 1.08 M
PFIZER INC: 715,295
Peapod Lane Capital LLC: 589,216
Stonepine Capital Management, LLC: 563,913
BANK OF NOVA SCOTIA: 459,194
27.34% of AN2 Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 8.61 M shares in the last 24 months. This purchase volume represents approximately $9.21 M in transactions.